Professor | Wei Xu | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Wei Xu
Contact Information	nxuwei11@fudan.edu.cn
Language ability	Chinese, English
Province	Shanghai

Upload Avatar (500 x 500)

Name

Wei Xu

Contact Information

nxuwei11@fudan.edu.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	Fudan University
Faculty	Basic Medical Sciences
Academic Background & Achievements	1999.09—2004.07 Bachelor's Degree in Medical Laboratory Science: Beihua University 2004.09—2007.07 Master's Degree in Clinical Laboratory Science: Beihua University 2011.09—2014.07 Ph.D. in Pathogen Biology: Fudan University
Work Experience	2007.08—2011.07 - Taizhou Hospital, Zhejiang Province - Role not specified 2014.08—2016.09 - Shanghai Center for Disease Control and Prevention - Role not specified 2016.10—2019.10 - Postdoctoral Researcher, School of Basic Medical Sciences, Fudan University 2019.11—Present - Assistant Researcher, School of Basic Medical Sciences, Fudan University
Awards	2013: 'One Health' Fund, Shanghai Medical College, Fudan University

University/Lab Affiliation and Title

Fudan University

Faculty

Basic Medical Sciences

Academic Background & Achievements

1999.09—2004.07 Bachelor's Degree in Medical Laboratory Science: Beihua University
2004.09—2007.07 Master's Degree in Clinical Laboratory Science: Beihua University
2011.09—2014.07 Ph.D. in Pathogen Biology: Fudan University

Work Experience

2007.08—2011.07 - Taizhou Hospital, Zhejiang Province - Role not specified
2014.08—2016.09 - Shanghai Center for Disease Control and Prevention - Role not specified
2016.10—2019.10 - Postdoctoral Researcher, School of Basic Medical Sciences, Fudan University
2019.11—Present - Assistant Researcher, School of Basic Medical Sciences, Fudan University

Awards

2013: 'One Health' Fund, Shanghai Medical College, Fudan University

Areas of Focus	Biomedicine, Virus Fusion/Inhibition of Emerging and Re-emerging Viral Infections
Publications	A protein-based, long-acting HIV-1 fusion inhibitor with an improved pharmacokinetic profile, Xu W#, Cong Z#, Duan Q#, Wang Q, Su S, Wang R, Lu L, Xue J, Jiang S, 2022 A Modified Fibronectin Type III Domain-Conjugated, Long-Acting Pan-Coronavirus Fusion Inhibitor with Extended Half-Life, Duan Q, Xia S, Jiao F, Wang Q, Wang R, Lu L, Jiang S, Xu W, 2022 A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs, Liu Z#, Zhou J#, Xu W#, Deng W#, Wang Y#, Wang M#, Wang Q, Hsieh M, Dong J, Wang X, Huang W, Xing L, He M, Tao C, Xie Y, Zhang Y, Wang Y, Zhao J, Yuan Z, Qin C, Jiang S, Lu L, 2022 Ring vaccination of COVID-19 vaccines in medium- and high-risk areas of countries with low incidence of SARS-CoV-2 infection, Xu W, Su S, Jiang S, 2021 Revisiting the mechanism of enfuvirtide and designing an analog with improved fusion inhibitory activity by targeting triple sites in gp41, Xu W, Pu J, Su S, Hua C, Su X, Wang Q, Jiang S, Lu L, 2019 IgG Fc-binding motif-conjugated HIV-1 fusion inhibitor exhibits improved potency and in vivo half-life: Potential application in combination with broad neutralizing antibodies, Bi W#, Xu W#, Cheng L, Xue J, Wang Q, Yu F, Xia S, Wang Q, Li G, Qin C, Lu L, Su L, Jiang S, 2019 The Antihistamine Drugs Carbinoxamine Maleate and Chlorpheniramine Maleate Exhibit Potent Antiviral Activity Against a Broad Spectrum of Influenza Viruses, Xu W, Xia S, Pu J, Wang Q, Li P, Lu L, Jiang S, 2018 Synergistic effect resulting from combinations of a bifunctional HIV-1 antagonist with antiretroviral drugs, Xu W#, Wang Q#, Yu F, Lu L, Jiang S, 2014 Serological investigation of subclinical influenza A(H7H9) infection among healthcare and non-healthcare workers in Zhejiang Province, China, Xu W#, Lu L#, Shen B, Li J, Xu J, Jiang S*, 2013

Areas of Focus

Biomedicine, Virus Fusion/Inhibition of Emerging and Re-emerging Viral Infections

Publications

A protein-based, long-acting HIV-1 fusion inhibitor with an improved pharmacokinetic profile, Xu W#, Cong Z#, Duan Q#, Wang Q, Su S, Wang R, Lu L*, Xue J*, Jiang S*, 2022
A Modified Fibronectin Type III Domain-Conjugated, Long-Acting Pan-Coronavirus Fusion Inhibitor with Extended Half-Life, Duan Q, Xia S, Jiao F, Wang Q, Wang R, Lu L*, Jiang S*, Xu W*, 2022
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs, Liu Z#, Zhou J#, Xu W#, Deng W#, Wang Y#, Wang M#, Wang Q, Hsieh M, Dong J, Wang X, Huang W, Xing L, He M, Tao C, Xie Y, Zhang Y*, Wang Y*, Zhao J*, Yuan Z*, Qin C*, Jiang S*, Lu L*, 2022
Ring vaccination of COVID-19 vaccines in medium- and high-risk areas of countries with low incidence of SARS-CoV-2 infection, Xu W, Su S, Jiang S, 2021
Revisiting the mechanism of enfuvirtide and designing an analog with improved fusion inhibitory activity by targeting triple sites in gp41, Xu W, Pu J, Su S, Hua C, Su X, Wang Q, Jiang S*, Lu L*, 2019
IgG Fc-binding motif-conjugated HIV-1 fusion inhibitor exhibits improved potency and in vivo half-life: Potential application in combination with broad neutralizing antibodies, Bi W#, Xu W#, Cheng L, Xue J, Wang Q, Yu F, Xia S, Wang Q, Li G, Qin C, Lu L*, Su L*, Jiang S*, 2019
The Antihistamine Drugs Carbinoxamine Maleate and Chlorpheniramine Maleate Exhibit Potent Antiviral Activity Against a Broad Spectrum of Influenza Viruses, Xu W, Xia S, Pu J, Wang Q, Li P, Lu L*, Jiang S*, 2018
Synergistic effect resulting from combinations of a bifunctional HIV-1 antagonist with antiretroviral drugs, Xu W#, Wang Q#, Yu F, Lu L*, Jiang S*, 2014
Serological investigation of subclinical influenza A(H7H9) infection among healthcare and non-healthcare workers in Zhejiang Province, China, Xu W#, Lu L#, Shen B, Li J, Xu J, Jiang S*, 2013

Biomedicine Virus Fusion Inhibition Emerging Viruses Re-Emerging Viruses Viral Infections Hiv Influenza Covid-19 Pathogen Biology

Tao Shen - Peking University

Gao Wei Hu - Fudan University

Jian Dong Huo - Guangzhou Medical University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us